Imunon Announces 11.1 Month Increase in Overall Survival in Patients With Newly Diagnosed, Advanced Ovarian Cancer Treated With Imnn-001
Imunon宣佈,接受Imnn-001治療的新診斷、晚期卵巢癌患者的總體生存期增加了11.1個月。
Imunon Announces 11.1 Month Increase in Overall Survival in Patients With Newly Diagnosed, Advanced Ovarian Cancer Treated With Imnn-001
Imunon宣佈,接受Imnn-001治療的新診斷、晚期卵巢癌患者的總體生存期增加了11.1個月。
使用瀏覽器的分享功能,分享給你的好友吧